To explore the possible mechanisms underlying the forementioned effects of full-length LRIG2 and LRIG2 ectodomain on the glioblastomas, we examined whether LRIG2 or LRIG2ecto could interact with EGFR. The gene discussed is EGFR; the disease is glioblastoma.